Life Experience of People Aged 60 and Over Living With HIV (PVVIH)

January 14, 2022 updated by: Centre Hospitalier René Dubos

Life Experience of People Aged 60 and Over Living With HIV: Quantitative Sociological Study

The purpose of this study is to Assess the impact of HIV on the life course of patients aged 60 and over.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

COREVIH IDF Nord and CERMES3 conducted a first qualitative survey of 32 HIV patients aged 60 and over. The study, in the form of an individual interview, aimed to identify the difficulties that PLWHIV may encounter in their life course, to question their future and the impact that HIV could have.

From this study, a questionnaire was drawn up covering the points raised by the qualitative study. The questionnaire was designed by doctors of the four hospitals that participated in the first study and a sociologist from CERMES3.

After patient's oral agreement obtained, the study questionnaire "Sociological study PVHIV ≥ 60 years" will be given to the patient for completion.

Study Type

Observational

Enrollment (Actual)

225

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Clichy, France, 92110
        • Hospital Beaujon, Clichy / Médecine Interne
      • Paris, France, 75006
        • Université Paris Descartes - CERMES3
      • Paris, France, 75018
        • Hôpital Bichat Claude-Bernard - Service de Maladies Infectieuses et Tropicales
      • Paris, France, 75018
        • Hôpital Bichat Claude-Bernard -COREVIH Ile de France Nord
      • Pontoise, France, 95300
        • Centre Hospitalier René Dubos
      • Saint-Denis, France, 93200
        • Hospital Delafontaine, Saint-Denis / Maladie infectieuse

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

People aged 60 and over living with HIV

Description

Inclusion Criteria :

People aged 60 and over living with HIV and view in consultation

Patient participation agreement obtained

Exclusion criteria :

People living with HIV less than 60 years old

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Determine the impact of HIV in the life cours of people aged 60 and over and the questioning of the future.
Time Frame: Through study completion, an average of 6 month
People aged 60 and over will answer to a sociological questionnaire to identify the impact of HIV in their life cours and the questioning of the future, directly or indirectly linked to HIV.
Through study completion, an average of 6 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Centre Hospitalier René Dubos

Investigators

  • Principal Investigator: Laurent Blum, Dr, Centre Hospitalier René Dubos

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 18, 2021

Primary Completion (Actual)

June 24, 2021

Study Completion (Actual)

June 24, 2021

Study Registration Dates

First Submitted

June 1, 2021

First Submitted That Met QC Criteria

October 6, 2021

First Posted (Actual)

October 19, 2021

Study Record Updates

Last Update Posted (Actual)

January 18, 2022

Last Update Submitted That Met QC Criteria

January 14, 2022

Last Verified

June 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CHRD1321

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Virus-HIV

Clinical Trials on Cohorte

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe